Skip to content

Management of Placenta Accreta Spectrum

Management of Placenta Accreta Spectrum

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04609527
Enrollment
30
Registered
2020-10-30
Start date
2020-10-16
Completion date
2021-12-31
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Accreta, Placenta Previa

Keywords

placenta, accreta, praevia, hyterectomy, PPH

Brief summary

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it.

Detailed description

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it. 1. surgical management of placenta accreta 2. short term follow up to the outcomes 3. long term follow up

Interventions

PROCEDUREManagement of placenta accreta spectrum

Conservative and radical (hysterectomy) treatment of placenta accreta. Follow up to the patients to detect the impact of treatment imposed A novel technique which early identification and repait of uterine wall defects resulted from invasion of the uterine wall by the placenta.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

All women with placenta praevia and previous scar in the uterus. Surgical management and follow up will be defined

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* All placenta accreta e high possibility of placenta accrete * consent * easy follow up visits

Exclusion criteria

* bleeding tendency * associated medical disorder hypertension, diabetes, preeclapsia..

Design outcomes

Primary

MeasureTime frameDescription
Failure of the novel conservative management3 hoursNeed to do peripartum hysterectomy or patient death
Estimated amount of blood loss6 hoursThe estimated amount of blood loss during and after surgery

Countries

Egypt

Contacts

Primary ContactOsama Abdalmageed
drosamast@aun.edu.eg01012234876
Backup Contactmaha said
drmahasaid2014@gmail.com01013464458

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026